News AbbVie, Gilead target sick hepatitis C patients in EU Competing hepatitis C combination drugs from AbbVie and Gilead are now approved in the EU, as the companies aim to treat patients who cannot be cured with established regimens.
News Study backs HIV testing in GP surgeries in high-risk areas GP surgeries should test new patients for HIV in areas of high prevalence as it is cost-effective, according to a new study.
News Gilead's new blockbuster HIV combination nears filing Pharma looks to file bictegravir and F/TAF later this year.
News Call for inquiry into NHS contaminated blood scandal Former health secretary says scandal was "criminal" cover-up.
Oncology Getting predictive technologies to patients, with Concr Dr Irina Babina, CEO of oncology R&D platform Concr, discusses how current regulatory frameworks were built for static diagnostics.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
